Introduction to the Supplement, "Cancer Therapy With Antibodies and Immunoconjugates"

被引：0

作者：

Goldenberg, David M. ^{[1
]}

机构：

[1] Ctr Mol Med & Immunol, Garden State Canc Ctr, Belleville, NJ USA

来源：

CANCER | 2010年 / 116卷 / 04期

关键词：

antibodies; cancer; imaging; immunotherapy; radioimmunotherapy; RADIOIMMUNOTHERAPY; PROSPECTS;

D O I：

10.1002/cncr.24786

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

This supplement includes 16 representative articles presented at the 12(th) Conference on Cancer Therapy With Antibodies and Immunconjugates; Parsippany, New Jersey, October 16-18, 2008, encompassing cancer treatment with unconjugated and isotope-conjugated antibodies targeting selective cancer biomarkers. Cancer 2010;116(4 suppl):1011-2. (C) 2010 American Cancer Society.

引用

页码：1011 / 1012

页数：2

共 6 条

[1] Introduction to the eleventh conference on cancer therapy with antibodies and immunoconjugates [J].

Goldenberg, David M. .

CLINICAL CANCER RESEARCH, 2007, 13 (18) :5499S-5500S

[2] Advances in radioimmunotherapy in the age of molecular engineering and pretargeting [J].

Sharkey, RM ;

Goldenberg, DM .

CANCER INVESTIGATION, 2006, 24 (01) :82-97

[3] Targeted therapy of cancer: New prospects for antibodies and immunoconjugates [J].

Sharkey, Robert M. ;

Goldenberg, David M. .

CA-A CANCER JOURNAL FOR CLINICIANS, 2006, 56 (04) :226-243

[4]

Sharkey RM, 2008, CURR OPIN INVEST DR, V9, P1302

[5] A re-examination of radioimmunotherapy in the treatment of non-Hodgkin lymphoma: prospects for dual-targeted antibody/radioantibody therapy [J].

Sharkey, Robert M. ;

Press, Oliver W. ;

Goldenberg, David M. .

BLOOD, 2009, 113 (17) :3891-3895

[6]

2008, CANC BIOTHER RADIOPH, V23, P505

← 1 →